Novo-Passit, 30 pcs.

Pharmacotherapeutic group

Sedative of herbal origin

ATX code: N05CM

Pharmacological action

It is a combined medicine, the pharmacological activity of which is due to its constituent herbal extract components with predominantly sedative (sedative) action and guaifenesin, which has anxiolytic (anti-anxiety) effect.

Indications

• Neurasthenia and neurotic reactions, accompanied by irritability, anxiety, fear, fatigue, absent-mindedness.
• “Manager syndrome” (a state of constant mental stress).
• Insomnia (mild forms).
• Headaches caused by nervous tension.
• Migraine.
• Functional diseases of the gastrointestinal tract (dyspeptic syndrome, irritable bowel syndrome).
• As a symptomatic remedy for neurocirculatory dystonia and menopausal syndrome.
• Itchy dermatoses (atopic and seborrheic eczema, urticaria) caused by psychological stress.

Pharmacological effect

Pharmacotherapeutic group
Herbal sedative

ATX code: N05CM

Pharmacological action
A combined drug, the pharmacological activity of which is due to its constituent components of an extract based on medicinal plant raw materials with a predominantly sedative (calming) effect and guaifenesin, which has an anxiolytic (anti-anxiety) effect.

Special instructions

During treatment with the drug you should not drink alcoholic beverages.
While taking Novo-Passit, especially patients with fair skin, should avoid exposure to ultraviolet radiation (prolonged exposure to direct sunlight, visiting a solarium).
If symptoms of the disease persist or the condition worsens while using the drug for 7 days, you should inform your doctor.

Impact on the ability to drive vehicles and machinery
During the period of use of the drug, you should refrain from performing potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions (including driving vehicles, working with moving mechanisms).

Active ingredient

Hawthorn fruits extra., Black elder flowers extra., Valerian leaves. rhizomes with roots

Composition

Active components:
Novo-Passita dry extract (1:6.5) (obtained from valerian officinalis rhizomes with roots (5 h), lemon balm herb (2 h), St. John’s wort herb (5 h), hawthorn leaves and flowers (5 h), passionflower incarnate herb (1 h), common hop fruit (5 h), black elderberry flowers (2 h)) 157.5 mg; guaifenesin 200.0 mg

Excipients:
silicon dioxide 2.0 mg, microcrystalline cellulose 96.0 mg, glyceryl tribehenate 10.0 mg, magnesium stearate 10.0 mg, lactose monohydrate up to 800.0 mg

Shell:
opadry “AMB 80W31115” green (polyvinyl alcohol 45.52%, titanium dioxide 26.5%, talc 20.0%, soy lecithin 2.0%, xanthan gum 0.48%, quinoline yellow dye 2.5%, iron oxide yellow dye 2.0%, indigo carmine dye 1.0%) 24.0 mg.

Pregnancy

During pregnancy, the drug is prescribed only for absolute indications, if the expected effect for the mother exceeds the possible risk for the fetus.
If it is necessary to use the drug during breastfeeding, breastfeeding should be discontinued.

Contraindications

Hypersensitivity to the components of the drug, especially to guaifenesin, lactose intolerance, lactase deficiency, glucose-galactose malabsorption, myasthenia, children under 12 years of age.

With caution
Acute diseases of the gastrointestinal tract, liver diseases, alcoholism, brain diseases or injuries, epilepsy, children over 12 years of age.

Side Effects

Patients usually tolerate the drug well. However, in rare cases, allergic reactions, exanthema, dizziness, fatigue, drowsiness, mild muscle weakness, gastrointestinal disorders (nausea, vomiting, cramps, heartburn, diarrhea, constipation), decreased concentration, which quickly disappear after discontinuation of the drug, may appear.
If any of these side effects get worse, or you notice any other side effects not listed in the instructions, tell your doctor.

Interaction

When taking Novo-Passit and other medications simultaneously, their effect may be enhanced or weakened. Before starting to take the drug simultaneously with other medications, you should consult your doctor.
The drug enhances the effect of alcohol and other substances that depress the central nervous system.
Medicines used to relax skeletal muscles (central muscle relaxation) may increase the risk of side effects of the drug, primarily muscle weakness.
St. John’s wort extract contained in the drug reduces the effectiveness of hormonal contraception, as well as drugs used primarily after transplantation to reduce the risk of rejection of a transplanted organ or tissue (immunosuppressive drugs), drugs intended for the treatment of AIDS, cardiovascular diseases, bronchial diseases and the prevention of thromboembolism. Therefore, before starting to take Novo-Passit along with these medications, you should consult your doctor.

Overdose

An overdose initially manifests itself as a feeling of depression and drowsiness. Later, these symptoms may be accompanied by nausea, mild muscle weakness, joint pain, and a feeling of heaviness in the stomach. If symptoms of overdose appear, the drug should be discontinued. First aid: gastric lavage. Treatment is symptomatic. You need to see a doctor.

Storage conditions

Store at a temperature not exceeding 25 °C in the original packaging (pack).
Keep out of the reach of children!

Shelf life

3 years.
Do not use after expiration date.

Manufacturer

Teva Czech Enterprises s.r.o., Czech Republic